THYROCARE TECHNOLOGIES share price has zoomed 7% and is presently trading at Rs 689.7.
Meanwhile, the BSE HEALTHCARE index is at 38,804.3 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are HIKAL CHEMIC (up 4.8%) and Sanofi India (up 3.1%).
Torrent Pharma (down 3.2%) and DR. LAL PATHLABS (down 1.7%) are among the top losers today.
Over the last one year, THYROCARE TECHNOLOGIES has moved up from Rs 583.5 to Rs 689.7, registering a gain of Rs 106.2 (up 18.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 26,789.0 to 38,804.3, registering a gain of 44.9% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GSK Pharma (up 96.3%), Jubilant Pharmova (up 94.5%) and Lupin (up 93.6%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 80,197.5 (down 0.3%).
The top losers among the BSE Sensex today are Hindustan Unilever (down 3.0%) and Bajaj Finance (down 2.3%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.
In the meantime, NSE Nifty is at 24,409.1 (down 0.3%). Hindustan Unilever and Tata Consumer Products are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 66,384.8 to 80,197.5, registering a gain of 13,812.7 points (up 20.8%).
THYROCARE TECHNOLOGIES net profit grew 41.9% YoY to Rs 243 million for the quarter ended June 2024, compared to a profit of Rs 171 million a year ago. Net sales rose 16.3% to Rs 1,569 million during the period as against Rs 1,349 million in April-June 2023.
For the year ended March 2023, THYROCARE TECHNOLOGIES reported 63.5% decrease in net profit to Rs 644 million compared to net profit of Rs 1,761 million during FY22. Revenue of the company fell 10.6% to Rs 5,267 million during FY23.
The current Price to earnings ratio of THYROCARE TECHNOLOGIES, based on rolling 12 month earnings, stands at 47.9.
Equitymaster requests your view! Post a comment on "THYROCARE TECHNOLOGIES Gains 7%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!